BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 23966291)

  • 1. FOXO transcription factors control E2F1 transcriptional specificity and apoptotic function.
    Shats I; Gatza ML; Liu B; Angus SP; You L; Nevins JR
    Cancer Res; 2013 Oct; 73(19):6056-67. PubMed ID: 23966291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer.
    Lu Z; Luo RZ; Peng H; Huang M; Nishmoto A; Hunt KK; Helin K; Liao WS; Yu Y
    Oncogene; 2006 Jan; 25(2):230-9. PubMed ID: 16158053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of E2F1 during ER stress is required to induce apoptosis.
    Pagliarini V; Giglio P; Bernardoni P; De Zio D; Fimia GM; Piacentini M; Corazzari M
    J Cell Sci; 2015 Mar; 128(6):1166-79. PubMed ID: 25616897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FoxO proteins' nuclear retention and BH3-only protein Bim induction evoke mitochondrial dysfunction-mediated apoptosis in berberine-treated HepG2 cells.
    Shukla S; Rizvi F; Raisuddin S; Kakkar P
    Free Radic Biol Med; 2014 Nov; 76():185-99. PubMed ID: 25128467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apoptosis signal-regulating kinase 1 is a direct target of E2F1 and contributes to histone deacetylase inhibitor-induced apoptosis through positive feedback regulation of E2F1 apoptotic activity.
    Tan J; Zhuang L; Jiang X; Yang KK; Karuturi KM; Yu Q
    J Biol Chem; 2006 Apr; 281(15):10508-15. PubMed ID: 16476732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphatidylinositol 3-kinase signaling in proliferating cells maintains an anti-apoptotic transcriptional program mediated by inhibition of FOXO and non-canonical activation of NFkappaB transcription factors.
    Terragni J; Graham JR; Adams KW; Schaffer ME; Tullai JW; Cooper GM
    BMC Cell Biol; 2008 Jan; 9():6. PubMed ID: 18226221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The FoxO-BNIP3 axis exerts a unique regulation of mTORC1 and cell survival under energy stress.
    Lin A; Yao J; Zhuang L; Wang D; Han J; Lam EW; Gan B
    Oncogene; 2014 Jun; 33(24):3183-94. PubMed ID: 23851496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. E2F transcription factor 1 regulates cellular and organismal senescence by inhibiting Forkhead box O transcription factors.
    Xie Q; Peng S; Tao L; Ruan H; Yang Y; Li TM; Adams U; Meng S; Bi X; Dong MQ; Yuan Z
    J Biol Chem; 2014 Dec; 289(49):34205-13. PubMed ID: 25344604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human TRIB2 is a repressor of FOXO that contributes to the malignant phenotype of melanoma cells.
    Zanella F; Renner O; García B; Callejas S; Dopazo A; Peregrina S; Carnero A; Link W
    Oncogene; 2010 May; 29(20):2973-82. PubMed ID: 20208562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apigenin inhibits prostate cancer progression in TRAMP mice via targeting PI3K/Akt/FoxO pathway.
    Shukla S; Bhaskaran N; Babcook MA; Fu P; Maclennan GT; Gupta S
    Carcinogenesis; 2014 Feb; 35(2):452-60. PubMed ID: 24067903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Transcriptional Regulation of FOXO Genes in Thyrocytes.
    Franz F; Weidinger C; Krause K; Gimm O; Dralle H; Führer D
    Horm Metab Res; 2016 Sep; 48(9):601-6. PubMed ID: 27258970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nicotinic acetylcholine receptors induce c-Kit ligand/Stem Cell Factor and promote stemness in an ARRB1/ β-arrestin-1 dependent manner in NSCLC.
    Perumal D; Pillai S; Nguyen J; Schaal C; Coppola D; Chellappan SP
    Oncotarget; 2014 Nov; 5(21):10486-502. PubMed ID: 25401222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FOXP1 acts through a negative feedback loop to suppress FOXO-induced apoptosis.
    van Boxtel R; Gomez-Puerto C; Mokry M; Eijkelenboom A; van der Vos KE; Nieuwenhuis EE; Burgering BM; Lam EW; Coffer PJ
    Cell Death Differ; 2013 Sep; 20(9):1219-29. PubMed ID: 23832113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The E2F transcription factor 1 transactives stathmin 1 in hepatocellular carcinoma.
    Chen YL; Uen YH; Li CF; Horng KC; Chen LR; Wu WR; Tseng HY; Huang HY; Wu LC; Shiue YL
    Ann Surg Oncol; 2013 Nov; 20(12):4041-54. PubMed ID: 22911364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resveratrol induces growth arrest and apoptosis through activation of FOXO transcription factors in prostate cancer cells.
    Chen Q; Ganapathy S; Singh KP; Shankar S; Srivastava RK
    PLoS One; 2010 Dec; 5(12):e15288. PubMed ID: 21179458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of androgen receptor expression by phosphatidylinositol 3-kinase/Akt downstream substrate, FOXO3a, and their roles in apoptosis of LNCaP prostate cancer cells.
    Yang L; Xie S; Jamaluddin MS; Altuwaijri S; Ni J; Kim E; Chen YT; Hu YC; Wang L; Chuang KH; Wu CT; Chang C
    J Biol Chem; 2005 Sep; 280(39):33558-65. PubMed ID: 16061480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The HSP90 inhibitor XL888 overcomes BRAF inhibitor resistance mediated through diverse mechanisms.
    Paraiso KH; Haarberg HE; Wood E; Rebecca VW; Chen YA; Xiang Y; Ribas A; Lo RS; Weber JS; Sondak VK; John JK; Sarnaik AA; Koomen JM; Smalley KS
    Clin Cancer Res; 2012 May; 18(9):2502-14. PubMed ID: 22351686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Astrocyte elevated gene-1 is a proliferation promoter in breast cancer via suppressing transcriptional factor FOXO1.
    Li J; Yang L; Song L; Xiong H; Wang L; Yan X; Yuan J; Wu J; Li M
    Oncogene; 2009 Sep; 28(36):3188-96. PubMed ID: 19633686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-221 induces cell survival and cisplatin resistance through PI3K/Akt pathway in human osteosarcoma.
    Zhao G; Cai C; Yang T; Qiu X; Liao B; Li W; Ji Z; Zhao J; Zhao H; Guo M; Ma Q; Xiao C; Fan Q; Ma B
    PLoS One; 2013; 8(1):e53906. PubMed ID: 23372675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel function of FoxO transcription factors in thrombin-stimulated vascular smooth muscle cell proliferation.
    Mahajan SG; Fender AC; Meyer-Kirchrath J; Kurt M; Barth M; Sagban TA; Fischer JW; Schrör K; Hohlfeld T; Rauch BH
    Thromb Haemost; 2012 Jul; 108(1):148-58. PubMed ID: 22552808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.